Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Open Study of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder in Adults

NCT00305500 is registered in ClinicalTrials.gov with Abarbanel Mental Health Center as lead sponsor.

NCT NCT00305500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00305500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Open Study of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder in Adults
Lead sponsor
Abarbanel Mental Health Center
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2006
Completion date
December 31, 2006
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder